Protein tyrosine phosphatase 1B inhibitors for diabetes

By T. O. Johnson, J. Ermolieff, M. Jirousek. Nature reviews. Drug discovery, 2002

601 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/6913fcd8b826eaa70690c3401f59ee9aa537b9e0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. D. Hanahan

In Immunology

1. C. Hellberg
2. F. Böhmer
3. A. Ostman

In Molecular Biology

1. C. Hellberg
2. F. Böhmer
3. A. Ostman

Citations in the corpus

• Protein-tyrosine phosphatases and cancer (2006, background): “The develop-ment of suitable inhibitors for these enzymes will certainly benefit from extensive previous work, which has been mainly devoted to the development of inhibitors for PTP1B as a novel class of potential anti-diabetic compounds (for review see Ref”